1-14 of 14
Luca Dozza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

Elena Zamagni, Cristina Nanni, MD, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Mattia D'Agostino, MD, Rossella Ribolla, MD, Monica Galli, Manuela Racca, MD, Renato Zambello, Elena Rivolti, MD, Domenico Albano, MD, Annibale Versari, MD, Mariella Grasso, Rossella Troia, PharmD, Antonio Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, MD, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, MD PhD, Mario Boccadoro, Michele Cavo, Pellegrino Musto, Stefania Oliva
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-137412
Published: 2020
Journal Articles

Upfront Autologous Hematopoietic Stem-Cell Transplantation Improves Overall Survival in Comparison with Bortezomib-Based Intensification Therapy in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the Randomized Phase 3 EMN02/HO95 Study

Michele Cavo, Francesca Gay, MD, Meral Beksac, MD, Meletios A Dimopoulos, Lucia Pantani, MD PhD, Maria Teresa Petrucci, Luca Dozza, MSc, Bronno Van Der Holt, PhD, Sonja Zweegman, MDPhD, Elena Zamagni, Giuseppe A. Palumbo, MD PhD, Francesca Patriarca, Monica Galli, Vladimir Maisnar, MD PhD MBA, Markus Hansson, MD, Angelo Belotti, Ludek Pour, MD, Paula F Ypma, MD PhD, Mariella Grasso, Sandra Croockewit, MD, Massimo Offidani, Renato Zambello, Anna Marina Liberati, MD, Niels Frost Andersen, MD PhD, Annemiek Broyl, MD PhD, Rossella Troia, PharmD, Pellegrino Musto, Heinz Ludwig, MD, Anna Maria Morelli, MD, Roman Hajek, MD, Christoph Driessen, MD, Anders Waage, MD PhD, Peter Gimsing, DO, PhD, Ulf-Henrik Mellqvist, MD PhD, Thilo Zander, MD, Mario Boccadoro, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137575
Published: 2020
Journal Articles

Consolidation Treatment with VRD Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Trial of the European Myeloma Network (EMN02/HO95)

Pieter Sonneveld, MD PhD, Meral Beksac, MD, Bronno Van Der Holt, PhD, Meletios A Dimopoulos, Angelo Michele Carella, MD, Heinz Ludwig, MD, Sonja Zweegman, MD PhD, Thilo Zander, MD, Ruth Wester, MD, Roman Hajek, MD, Lucia Pantani, MD PhD, Luca Dozza, MSc, Francesca Gay, MD, Anna Maria Cafro, Luca De Rosa, Francesca Fioritoni, MD, Ulf-Henrik Mellqvist, MD PhD, Rossella Troia, PharmD, Niels Frost Andersen, MD PhD, Ka Lung Wu, MD PhD, Christoph Driessen, MD, Susana Carvalho, MD, Alexandra J. Croockewit, MD PhD, Fredrik Schjesvold, MDPhD, Massimo Offidani, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–48.
https://doi.org/10.1182/blood-2020-139337
Published: 2020
Journal Articles

Negative Selective Pressure Exerted By Maintenance Therapy Promotes the Extinction of Sub-Clones Carrying High-Risk Lesions in Multiple Myeloma

Carolina Terragna, Andrea Poletti, Vincenza Solli, Marina Martello, Enrica Borsi, Lucia Pantani, Agboyi Lakpo, Luca Cifarelli, Silvia Armuzzi, Rosalinda Termini, Elena Zamagni, MD, Paola Tacchetti, Serena Rocchi, Katia Mancuso, Serena Rocchi, Ilaria Rizzello, Giulia Marzocchi, Nicoletta Testoni, Luca Dozza, Maria Teresa Petrucci, Anna Marina Liberati, Giuseppe Rossi, Mario Boccadoro, Michele Cavo
Journal: Blood
Blood (2019) 134 (Supplement_1): 1778.
https://doi.org/10.1182/blood-2019-127799
Published: 2019
Journal Articles

MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial

Elena Zamagni, MD, Cristina Nanni, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Paola Omedé, Rossella Ribolla, MD, Monica Galli, Manuela Racca, Renato Zambello, Barbara Gamberi, MD, Domenico Albano, Annibale Versari, Mariella Grasso, Rossella Troia, Tonino Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, Prof, MD PhD, Mario Boccadoro, Michele Cavo, Stefania Oliva
Journal: Blood
Blood (2019) 134 (Supplement_1): 4321.
https://doi.org/10.1182/blood-2019-125134
Published: 2019
Journal Articles

Serum Free Light Chain Assay As an Additional Tool for Defining Response and Progressive Disease in Immunoglobulin Secretory Multiple Myeloma

Paola Tacchetti, Serena Rocchi, Luca Dozza, Elena Zamagni, MD, Isola Caratozzolo, MD, Ilaria Rizzello, Alessio Fusco, MD, Gabriella De Cicco, MD, Lucia Pantani, MD, Katia Mancuso, Carolina Terragna, Nicoletta Testoni, Pier Luigi Luigi Zinzani, MD, Michele Cavo
Journal: Blood
Blood (2019) 134 (Supplement_1): 1796.
https://doi.org/10.1182/blood-2019-128715
Published: 2019
Journal Articles

Standardization of 18F-FDG PET/CT According to Deauville Criteria for MRD Evaluation in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Joined Analysis of Two Prospective Randomized Phase III Trials

Elena Zamagni, MD, Cristina Nanni, Luca Dozza, MSc, Thomas Carlier, Paola Tacchetti, MD PhD, Annibale Versari, Stephane Chauvie, Andrea Gallamini, MD, Michel Attal, Barbara Gamberi, MD, Denis Caillot, Francesca Patriarca, MD, Margaret Macro, Mario Boccadoro, MD, Laurent Garderet, Stefano Fanti, Aurore Perrot, Francesca Gay, MD, Pieter Sonneveld, MDPhD, Lionel Karlin, MD, Michele Cavo, MD, Caroline Bodet-Milin, Philippe Moreau, Francoise Kraeber-Bodere
Journal: Blood
Blood (2018) 132 (Supplement 1): 257.
https://doi.org/10.1182/blood-2018-99-111321
Published: 2018
Journal Articles

Double Vs Single Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: Long-Term Follow-up (10-Years) Analysis of Randomized Phase 3 Studies

Michele Cavo, MD, Hartmut Goldschmidt, MD, Laura Rosinol, MD PhD, Lucia Pantani, MD, Sonja Zweegman, MDPhD, Hans Jürgen Salwender, MD, Juan Jose Lahuerta, MD PhD, Henk M. Lokhorst, MD PhD, Maria Teresa Petrucci, MD, Igor Blau, MD PhD, Albert Oriol, MD, Nicoletta Testoni, BSc, Katja Weisel, MD, Rafael Rios, MD PhD, Francesca Patriarca, MD, Jesús Blanchard, MD, Luca Dozza, MSc, Maria-Victoria Mateos, MD PhD, Monica Galli, MD, Jesus F San-Miguel, MD PhD, Mario Boccadoro, MD, Joan Blade, MD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 124.
https://doi.org/10.1182/blood-2018-99-112899
Published: 2018
Journal Articles

Bortezomib-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone before and after Double Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase 3 Gimema-MMY-3006 Study and Prognostic Score for Survival Outcomes

Paola Tacchetti, MD PhD, Luca Dozza, MSc, Francesco Di Raimondo, MD, Claudia Crippa, MD, Elena Zamagni, MD, Sara Bringhen, MD, Lucia Pantani, MD, Massimo Offidani, MD, Vittorio Montefusco, MD, Franco Narni, MD, Katia Mancuso, MD, Claudia Cellini, MD, Antonio Spadano, MD, Norbert Pescosta, MD, Luca Baldini, MD, Carolina Terragna, Chiara Nozzoli, MD, Renato Zambello, MD, Daniele Derudas, MD, Stelvio Ballanti, MD, Michele Cavo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 125.
https://doi.org/10.1182/blood-2018-99-116716
Published: 2018
Journal Articles

Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study

Michele Cavo, MD, Roman Hájek, MD, Lucia Pantani, MD, Meral Beksac, MD, Stefania Oliva, MD, Luca Dozza, Hans Erik Johnsen, MD Professor, Maria Teresa Petrucci, MD, Ulf-Henrik Mellqvist, MD, Concetta Conticello, MD, Christoph Driessen, MD, Giulia Marzocchi, BSc, Meletios A. Dimopoulos, Sonja Zweegman, MD PhD, Ka Lung Wu, MD, Barbara Gamberi, MD, Claudia Crippa, MD, Bronno van der Holt, Massimo Offidani, MD, Ruth Wester, Iolanda Donatella Vincelli, MD, Rossella Troia, Petra Cornelisse, Mario Boccadoro, MD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 397.
https://doi.org/10.1182/blood.V130.Suppl_1.397.397
Published: 2017
Journal Articles

High-Risk Cytogenetics in Newly Diagnosed Multiple Myeloma: Prognostic Relevance of Co-Segregations and Analysis of the Role of Double Versus Single Autotransplantation

Nicoletta Testoni, BSc, Giulia Marzocchi, BSc, Lucia Pantani, MD, Gaia Ameli, BSc, Luca Dozza, Francesca Gay, MD, Maria Teresa Petrucci, MD, Francesco Di Raimondo, MD, Francesca Patriarca, MD, Monica Galli, MD PhD, Vittorio Montefusco, MD, Barbara Gamberi, MD, Claudia Crippa, MD, Donatella Iolanda Vincelli, MD, Massimo Offidani, MD, Carolina Terragna, Katia Mancuso, MD, Serena Rocchi, MD, Pieter Sonneveld, MDPhD, Mario Boccadoro, Michele Cavo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 394.
https://doi.org/10.1182/blood.V130.Suppl_1.394.394
Published: 2017
Journal Articles

Bortezomib-Based Therapy Overcomes the Adverse Impact of Renal Impairment in Transplant Eligible Patients: An Analysis of the Prospective Randomized EMN02/HO95 Study

Meletios A. Dimopoulos, Efstathios Kastritis, Roman Hajek, Luca Dozza, Meral Beksac, MD, Alessandra Larocca, Hans Erik Johnsen, MD Professor, Ulf-Henrik Mellqvist, MD, Anders Waage, MD PhD, Sonja Zweegman, MD PhD, Heinz Ludwig, MD, Lucia Pantani, MD, Andrew Spencer, MD, Anna Pascarella, Marina Martello, Susana Carvalho, Hlif Steingrimsdottir, MD, Claudia Cellini, MD, Petra Cornelisse, Rossella Troia, Patrizia Tosi, MD, Bronno van der Holt, Mario Boccadoro, Pieter Sonneveld, MDPhD, Michele Cavo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4545.
https://doi.org/10.1182/blood.V130.Suppl_1.4545.4545
Published: 2017
Journal Articles

Double Autologous Stem Cell Transplantation Significantly Prolongs Progression-Free Survival and Overall Survival in Comparison with Single Autotransplantation in Newly Diagnosed Multiple Myeloma: An Analysis of Phase 3 EMN02/HO95 Study

Michele Cavo, MD, Francesca Maria Gay, Francesca Patriarca, MD, Elena Zamagni, MD, Vittorio Montefusco, MD, Luca Dozza, Monica Galli, MD PhD, Sara Bringhen, Nicoletta Testoni, BSc, Mariella Grasso, MD, Stelvio Ballanti, MD, Paola Tacchetti, MD, Giampietro Semenzato, MD, Anna Marina Liberati, Giulia Benevolo, Mauro Spriano, MD, Paolo Di Bartolomeo, MD, Tommaso Caravita di Toritto, MD, Angelo D. Palmas, MD, Anna Maria Cafro, MD, Fortunato Morabito, MD, Pellegrino Musto, MD, Rita Rizzi, MD, Antonio Palumbo, MD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 401.
https://doi.org/10.1182/blood.V130.Suppl_1.401.401
Published: 2017
Journal Articles

Definition of a Prognostic Risk-Classifier Based on SNPs Array Analysis of Copy Number Alterations in Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients

Carolina Terragna, Vincenza Solli, Andrea Poletti, Barbara Santacroce, Marina Martello, Alessandra Larocca, Luca Dozza, Anna Baraldi, MD, Lucia Pantani, MD, Adelina Sementa, Paola Tacchetti, MD, Norbert Pescosta, MD, Elena Zamagni, MD, Giovanna Leonardi, Caterina Musolino, MD, Giulia Marzocchi, BSc, Letizia Canepa, MD, Gaia Ameli, BSc, Beatrice Zannetti, Anna Pascarella, Enrica Borsi, Luca De Rosa, Nicoletta Testoni, BSc, Giovanni Martinelli, MD, Pieter Sonneveld, MDPhD, Michele Cavo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3053.
https://doi.org/10.1182/blood.V130.Suppl_1.3053.3053
Published: 2017